NCT07773922

Brief Summary

Forty-eight participants between the age of 35 to 55years patient treated with Taxane chemotherapy, will be randomly divided into two equal groups, each comprising 24 patients.

  • Group (A): Consists of twenty- four patients have chemo therapy Induced peripheral Neuropathy and will receive Otago exercise plus resistance exercise 3times per week for 8weeks
  • Group (B): Consists of twenty- four patients with Chemotherapy induced peripheral Neuropathy who will receive conventional physical therapy program including: resistance exercise for 8weeks , 3 times per week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

2 months

First QC Date

August 15, 2026

Last Update Submit

August 15, 2026

Conditions

Keywords

Otago Exercise ProgramChemotherapy-Induced Peripheral Neuropathy (CIPN)Muscle WeaknessMuscle StrengthCancer SurvivorsExercise TherapyRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Muscle strength of the lower limb muscles will be assessed using a Hand-Held Dynamometer (HHD).

    Muscle strength of the lower limb muscles will be assessed using a Hand-Held Dynamometer (HHD).

    Baseline and after 8 weeks

Secondary Outcomes (1)

  • Modified Total Neuropathy Score (mTNS)

    Baseline and after 8 weeks

Study Arms (2)

Otago Exercise Plus Resistance Exercise

EXPERIMENTAL

Participants will receive the Otago Exercise Program in addition to resistance exercises using elastic bands, three sessions per week for 8 weeks.

Behavioral: Otago Exercise Program

Resistance exercises

ACTIVE COMPARATOR

Participants will receive a conventional physical therapy program including resistance exercises with elastic bands, strengthening exercises, and lower limb exercises, three sessions per week for 8 weeks.

Behavioral: Resistance Exercise

Interventions

An individualized Otago Exercise Program including warm-up, lower limb strengthening, balance, walking, and flexibility exercises. The program is delivered three times per week for 8 weeks under the supervision of a physical therapist.

Otago Exercise Plus Resistance Exercise

resistance exercises with elastic bands, strengthening exercises, and lower limb exercises, three sessions per week for 8 weeks.

Resistance exercises

Eligibility Criteria

Age35 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 35-55 years. Patients undergoing taxane chemotherapy. Diagnosed with chemotherapy-induced peripheral neuropathy (CIPN). Able to understand and follow assessment and treatment instructions. Willing to provide written informed consent.

You may not qualify if:

  • Pre-existing neurological disorders (e.g., multiple sclerosis, stroke, or Parkinson's disease).
  • Symptomatic heart disease, including congestive heart failure, arrhythmia, or myocardial infarction within the previous 3 months.
  • Severe orthopedic conditions, fractures, or chronic debilitating diseases limiting participation in the exercise program.
  • Psychological, cognitive, or emotional disorders affecting participation. Uncooperative patients or those unable to follow the exercise protocol. Refusal or inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

1 Gamma street ,Giza, Egypt -postal code:12613

Giza, Egypt, 12613, Egypt

Location

MeSH Terms

Conditions

Muscle Weakness

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Cairo University

    faculty of physical therapy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

August 15, 2026

First Posted

August 19, 2026

Study Start

January 1, 2026

Primary Completion

March 1, 2026

Study Completion

April 1, 2026

Last Updated

August 19, 2026

Record last verified: 2026-08

Locations